Soleus Capital Management, L.P. - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 40 filers reported holding DICE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,716,800
-25.2%
80,000
-53.9%
0.41%
-19.8%
Q1 2023$4,969,257
-8.2%
173,4470.0%0.52%
-33.6%
Q4 2022$5,411,546
-50.2%
173,447
-67.6%
0.78%
-47.4%
Q3 2022$10,857,000
-14.2%
535,358
-34.4%
1.48%
-25.3%
Q2 2022$12,660,000
-32.7%
815,740
-17.1%
1.98%
-18.7%
Q1 2022$18,824,000
-8.3%
983,994
+21.3%
2.43%
+18.2%
Q4 2021$20,525,000
-28.8%
810,940
-7.8%
2.06%
-54.2%
Q3 2021$28,817,000879,9034.49%
Other shareholders
DICE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$102,737,57555.73%
Sands Capital Ventures, LLC 2,748,970$85,76823.49%
OUP Management Co., LLC 268,346$8,372,39513.67%
New Leaf Venture Partners, L.L.C. 371,693$11,596,8228.40%
RA Capital Management 6,848,911$213,686,0234.33%
VR Adviser, LLC 819,000$25,552,8004.30%
SVB FINANCIAL GROUP 42,358$1,321,5703.61%
Logos Global Management LP 660,000$20,592,0002.41%
Deep Track Capital, LP 1,734,143$54,105,2622.27%
Samsara BioCapital, LLC 202,773$6,326,5181.36%
View complete list of DICE THERAPEUTICS INC shareholders